Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos

Detalhes bibliográficos
Ano de defesa: 2014
Autor(a) principal: Rodrigues, Diego Alves lattes
Orientador(a): Queiroz Junior, Luiz Henrique Keng lattes
Banca de defesa: Queiroz Junior, Luiz Henrique Keng, Colnago, Luiz Alberto, Lião, Luciano Morais
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
dARK ID: ark:/38995/0013000008m7b
Idioma: por
Instituição de defesa: Universidade Federal de Goiás
Programa de Pós-Graduação: Programa de Pós-graduação em Química (IQ)
Departamento: Instituto de Química - IQ (RG)
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.bc.ufg.br/tede/handle/tede/7185
Resumo: The commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug.
id UFG-2_cdfa8ab700e517592118bd2ff5eecd07
oai_identifier_str oai:repositorio.bc.ufg.br:tede/7185
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Queiroz Junior, Luiz Henrique Kenghttp://lattes.cnpq.br/5071272851467384Martins, Felipe Terrahttp://lattes.cnpq.br/0466799995060671Queiroz Junior, Luiz Henrique KengColnago, Luiz AlbertoLião, Luciano Moraishttp://lattes.cnpq.br/5383109693086058Rodrigues, Diego Alves2017-04-19T14:24:54Z2014-09-01RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014.http://repositorio.bc.ufg.br/tede/handle/tede/7185ark:/38995/0013000008m7bThe commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug.A comercialização de medicamentos na maioria das vezes ocorre mediante suas formas sólidas, sendo que as caracteriscas dos fármacos devem ser conservadas durante todo processo de produção e estocagem. Mediante este fato os estudos de caracterização dos fármacos em estado sólido estão em constante crescimento. A RMN em estado sólido de alta resolução pode fornecer informações complementares importantes as atuais técnicas, através das mudanças dos deslocamentos químicos. O objetivo deste presente estudo é a caracterização dos fármacos Efavirenz (EVZ) e Oseltamivir pela técnica de ressonância magnética nuclear tanto em solução como em estado sólido aliado aos dados teóricos de cálculos computacionais. O fármaco Efavirenz foi caracterizado por Difratometria de raios X (DRX), ressonância magnética nuclear em solução (RMN de 1H e 13C{1H}) e de sólidos (RMN CPMAS e CPTOSS de 13C e15N), além do uso de cálculos teóricos em solução utilizando o modelo GIAO para uma atribuição inequívoca dos sinais de RMN. As mesmas técnicas de caracterização estrutural e cálculos teóricos foram utilizadas no fármaco Oseltamivir, rescendendo a técnica de Difratometria de raios X (DRX), sendo este fármaco até então considerado amorfo. Os dados obtidos pelas análises experimentais de RMN foram coerentes com a estrutura dos fármacos Efavirenz e Oseltamivir; e os resultados dos cálculos teóricos foram dispostos em tabelas, sendo realizado um trabalho de análises estatísticas de forma a correlacionar os dados experimentais com os dados teóricos, pela análise do desvio padrão (SD), desvio médio (MD), coeficiente linear (R). Notavelmente os valores teóricos dos deslocamentos químicos de RMN 1H e 13C em solução, obtidos com o nível de teoria DFT/B3LYP, possibilitaram para os fármacos em questão uma correlação considerável com os valores experimentais e permitiram associar um baixo custo computacional a uma boa precisão dos resultados obtidos. Desta forma utilizando experimentos de RMN em solução 1D e 2D aliados aos resultados dos cálculos teóricos computacionais foi possível a elucidação e atribuição de todos os sinais de RMN de 1H e 13C de ambos os fármacos. Experimentos refinados de RMN em estado sólido 1D (CP/TOSS de 13C e CP/MASS de15N) possibilitaram a identificação destes átomos em estado sólido. Aliados a cálculos teóricos GIPAW forneceram valiosas informações sobre as moléculas dentro da unidade assimétrica de cada fármaco.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfporUniversidade Federal de GoiásPrograma de Pós-graduação em Química (IQ)UFGBrasilInstituto de Química - IQ (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessRMN em estado sólidoEfavirenz (EVZ)OseltamivirCálculos teóricos computacionaisSolid state NMREfavirenz (EVZ)OseltamivirComputational theoretical calculationsCIENCIAS EXATAS E DA TERRA::QUIMICACaracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricosCharacterization of the crystalline phase of efavirenz and oseltamivir antiviral by NMR and theoretical calculationsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis663693921325415158600600600600782606674374119727815717003253031171952075167498588264571reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/96beb7a3-b407-49f6-a0fd-830688cd2cec/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/c19efe5a-17ec-4b82-9b40-bdfb69a296f6/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/eb9eb9dc-c505-4d92-b924-87ea5debe114/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/f1543613-8bd2-48b6-bf88-5d7ace88ae3c/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissertação - Diego Alves Rodrigues - 2014.pdfDissertação - Diego Alves Rodrigues - 2014.pdfapplication/pdf3563553http://repositorio.bc.ufg.br/tede/bitstreams/2b847c8d-f354-49be-8744-d8816de2fd91/download740d277eef5f559b08bdd1742e750f6eMD55tede/71852017-04-19 11:24:54.201http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/7185http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttps://repositorio.bc.ufg.br/tedeserver/oai/requestgrt.bc@ufg.bropendoar:oai:repositorio.bc.ufg.br:tede/12342017-04-19T14:24:54Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.por.fl_str_mv Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
dc.title.alternative.eng.fl_str_mv Characterization of the crystalline phase of efavirenz and oseltamivir antiviral by NMR and theoretical calculations
title Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
spellingShingle Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
Rodrigues, Diego Alves
RMN em estado sólido
Efavirenz (EVZ)
Oseltamivir
Cálculos teóricos computacionais
Solid state NMR
Efavirenz (EVZ)
Oseltamivir
Computational theoretical calculations
CIENCIAS EXATAS E DA TERRA::QUIMICA
title_short Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
title_full Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
title_fullStr Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
title_full_unstemmed Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
title_sort Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
author Rodrigues, Diego Alves
author_facet Rodrigues, Diego Alves
author_role author
dc.contributor.advisor1.fl_str_mv Queiroz Junior, Luiz Henrique Keng
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/5071272851467384
dc.contributor.advisor-co1.fl_str_mv Martins, Felipe Terra
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/0466799995060671
dc.contributor.referee1.fl_str_mv Queiroz Junior, Luiz Henrique Keng
dc.contributor.referee2.fl_str_mv Colnago, Luiz Alberto
dc.contributor.referee3.fl_str_mv Lião, Luciano Morais
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/5383109693086058
dc.contributor.author.fl_str_mv Rodrigues, Diego Alves
contributor_str_mv Queiroz Junior, Luiz Henrique Keng
Martins, Felipe Terra
Queiroz Junior, Luiz Henrique Keng
Colnago, Luiz Alberto
Lião, Luciano Morais
dc.subject.por.fl_str_mv RMN em estado sólido
Efavirenz (EVZ)
Oseltamivir
Cálculos teóricos computacionais
topic RMN em estado sólido
Efavirenz (EVZ)
Oseltamivir
Cálculos teóricos computacionais
Solid state NMR
Efavirenz (EVZ)
Oseltamivir
Computational theoretical calculations
CIENCIAS EXATAS E DA TERRA::QUIMICA
dc.subject.eng.fl_str_mv Solid state NMR
Efavirenz (EVZ)
Oseltamivir
Computational theoretical calculations
dc.subject.cnpq.fl_str_mv CIENCIAS EXATAS E DA TERRA::QUIMICA
description The commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug.
publishDate 2014
dc.date.issued.fl_str_mv 2014-09-01
dc.date.accessioned.fl_str_mv 2017-04-19T14:24:54Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/7185
dc.identifier.dark.fl_str_mv ark:/38995/0013000008m7b
identifier_str_mv RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014.
ark:/38995/0013000008m7b
url http://repositorio.bc.ufg.br/tede/handle/tede/7185
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 663693921325415158
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv 7826066743741197278
dc.relation.cnpq.fl_str_mv 1571700325303117195
dc.relation.sponsorship.fl_str_mv 2075167498588264571
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Química (IQ)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Instituto de Química - IQ (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/96beb7a3-b407-49f6-a0fd-830688cd2cec/download
http://repositorio.bc.ufg.br/tede/bitstreams/c19efe5a-17ec-4b82-9b40-bdfb69a296f6/download
http://repositorio.bc.ufg.br/tede/bitstreams/eb9eb9dc-c505-4d92-b924-87ea5debe114/download
http://repositorio.bc.ufg.br/tede/bitstreams/f1543613-8bd2-48b6-bf88-5d7ace88ae3c/download
http://repositorio.bc.ufg.br/tede/bitstreams/2b847c8d-f354-49be-8744-d8816de2fd91/download
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
740d277eef5f559b08bdd1742e750f6e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv grt.bc@ufg.br
_version_ 1846536696443699200